156 related articles for article (PubMed ID: 27467421)
1. Down's Syndrome-Transient Abnormal Myelopoiesis and Acute Leukaemia.
Bain B
Leuk Lymphoma; 1991; 3(5-6):309-17. PubMed ID: 27467421
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome of acute myeloid leukaemia in Down's syndrome.
Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM
Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
[TBL] [Abstract][Full Text] [Related]
3. Additional chromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome patients.
Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kitano N; Koike M
Acta Haematol; 1997; 98(2):109-12. PubMed ID: 9286308
[TBL] [Abstract][Full Text] [Related]
4. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
[TBL] [Abstract][Full Text] [Related]
5. "TAM"ing of the shrew-challenges in the diagnosis of Neonatal leukemia with Down's syndrome -A case report with literature review.
Manohar S; Jayakumar N
Indian J Pathol Microbiol; 2022; 65(3):699-701. PubMed ID: 35900507
[TBL] [Abstract][Full Text] [Related]
6. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
[TBL] [Abstract][Full Text] [Related]
7. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.
Mansini AP; Rubio PL; Rossi JG; Gallego MS; Medina A; Zubizarreta PA; Felice MS; Alonso CN
Arch Argent Pediatr; 2013 Dec; 111(6):532-6. PubMed ID: 24196768
[TBL] [Abstract][Full Text] [Related]
8. Transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
[TBL] [Abstract][Full Text] [Related]
9. Congenital Acute Megakaryoblastic Leukaemia in Down's Syndrome.
Lobato-Mendizabal E; Marín-Lopez A; López-de-la-Cruz G; Presno-Bernal M; Ruiz-Argüelles GJ
Leuk Lymphoma; 1990; 2(1-2):137-9. PubMed ID: 27456581
[TBL] [Abstract][Full Text] [Related]
10. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
11. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
Roy A; Roberts I; Vyas P
Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
[TBL] [Abstract][Full Text] [Related]
12. [Transient abnormal myelopoiesis followed by acute leukemia in children with Down syndrome].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Rinsho Ketsueki; 1990 Dec; 31(12):1939-44. PubMed ID: 2150419
[TBL] [Abstract][Full Text] [Related]
13. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
Fong CT; Brodeur GM
Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Down's syndrome with acute leukaemia.
Levitt GA; Stiller CA; Chessells JM
Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
[TBL] [Abstract][Full Text] [Related]
15. Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down's syndrome.
Ma SK; Wan TS; Chan GC; Ha SY; Fung LF; Chan LC
Br J Haematol; 2001 Mar; 112(3):824-5. PubMed ID: 11260090
[No Abstract] [Full Text] [Related]
16. Risks of leukaemia and solid tumours in individuals with Down's syndrome.
Hasle H; Clemmensen IH; Mikkelsen M
Lancet; 2000 Jan; 355(9199):165-9. PubMed ID: 10675114
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.
Creutzig U; Ritter J; Vormoor J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
Leukemia; 1996 Nov; 10(11):1677-86. PubMed ID: 8892666
[TBL] [Abstract][Full Text] [Related]
18. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder.
Groet J; McElwaine S; Spinelli M; Rinaldi A; Burtscher I; Mulligan C; Mensah A; Cavani S; Dagna-Bricarelli F; Basso G; Cotter FE; Nizetic D
Lancet; 2003 May; 361(9369):1617-20. PubMed ID: 12747884
[TBL] [Abstract][Full Text] [Related]
19. Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia.
Bain BJ; Béné MC
Acta Haematol; 2019; 141(4):232-244. PubMed ID: 30965338
[TBL] [Abstract][Full Text] [Related]
20. Isolated pericardial effusion and transient abnormal myelopoiesis in a fetus with Down's syndrome.
Hirashima C; Eguchi Y; Kohmura Y; Minakami H; Sato I
J Obstet Gynaecol Res; 2000 Aug; 26(4):303-6. PubMed ID: 11049242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
